i had posted this elsewhere thought you might be interested
http://eurheartj.oxfordjournals.org/con ... 1164.short
Effect of magnesium on restenosis
after percutaneous transluminal coronary angioplasty: a clinical and angiographic evaluation in a randomized patient population
Restenosis is a major clinical problem following successful percutaneous transluminal coronary angioplasty. Since magnesium has vasodilator and antithrombotic effects, this study was designed to evaluate its potential to decrease the rate of restenosis
In an open-labelled, randomized controlled study, 148 patients underwent successful coronary angioplasty. Ninety-eight patients were treated with ...[IV] magnesium sulphate ... 49 of them continued with oral supplements of magnesium hydroxide 600 mg. ... 50 patients served as controls (group C).
... A trend towards a lower rate of restenosis (>50% reduction in luminal diameter) was noticed in the magnesium groups (28/110, 25%) compared with the control group (20/53, 38%) P=0.10. ...
It is concluded that intravenous administration of magnesium in patients undergoing coronary angioplasty is feasible and safe and that the beneficial trend of magnesium to prevent acute recoil and late (within 6 months) restenosis
is encouraging and should promote further investigation in a larger patient population.